These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27713164)

  • 1. Upregulation of HSF1 in estrogen receptor positive breast cancer.
    Gökmen-Polar Y; Badve S
    Oncotarget; 2016 Dec; 7(51):84239-84245. PubMed ID: 27713164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
    Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
    Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.
    Vydra N; Janus P; Kus P; Stokowy T; Mrowiec K; Toma-Jonik A; Krzywon A; Cortez AJ; Wojtas B; Gielniewski B; Jaksik R; Kimmel M; Widlak W
    Elife; 2021 Nov; 10():. PubMed ID: 34783649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
    Ahmed W; Malik MFA; Saeed M; Haq F
    Mol Biol Rep; 2018 Dec; 45(6):2185-2192. PubMed ID: 30225582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is oncotype DX recurrence score (RS) of prognostic value once HER2-positive and. low-ER expression patients are removed?
    Milburn M; Rosman M; Mylander C; Tafra L
    Breast J; 2013; 19(4):357-64. PubMed ID: 23701403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
    Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
    Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat Shock Factor 1 Predicts Poor Prognosis of Gastric Cancer.
    Kim SJ; Lee SC; Kang HG; Gim J; Lee KH; Lee SH; Chun KH
    Yonsei Med J; 2018 Nov; 59(9):1041-1048. PubMed ID: 30328318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
    Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
    Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease.
    Gong DH; Fan L; Chen HY; Ding KF; Yu KD
    Oncotarget; 2016 May; 7(19):28570-8. PubMed ID: 27086913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer.
    Gökmen-Polar Y; Neelamraju Y; Goswami CP; Gu X; Nallamothu G; Janga SC; Badve S
    Mod Pathol; 2015 May; 28(5):677-85. PubMed ID: 25431237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.
    Santagata S; Hu R; Lin NU; Mendillo ML; Collins LC; Hankinson SE; Schnitt SJ; Whitesell L; Tamimi RM; Lindquist S; Ince TA
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18378-83. PubMed ID: 22042860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
    Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
    BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females.
    Almotwaa S; Elrobh M; AbdulKarim H; Alanazi M; Aldaihan S; Shaik J; Arafa M; Warsy AS
    PLoS One; 2018; 13(3):e0193095. PubMed ID: 29494616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status.
    Murphy NC; Biankin AV; Millar EK; McNeil CM; O'Toole SA; Segara D; Crea P; Olayioye MA; Lee CS; Fox SB; Morey AL; Christie M; Musgrove EA; Daly RJ; Lindeman GJ; Henshall SM; Visvader JE; Sutherland RL
    Int J Cancer; 2010 Mar; 126(6):1445-53. PubMed ID: 19676041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Oncotype DX assay necessary in strongly estrogen receptor-positive breast cancers?
    Lee JJ; Shen J
    Am Surg; 2011 Oct; 77(10):1364-7. PubMed ID: 22127090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.
    Figueroa JD; Yang H; Garcia-Closas M; Davis S; Meltzer P; Lissowska J; Horne HN; Sherman ME; Lee M
    Breast Cancer Res Treat; 2015 Apr; 150(2):457-466. PubMed ID: 25773928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
    Osborne JR; Port E; Gonen M; Doane A; Yeung H; Gerald W; Cook JB; Larson S
    J Nucl Med; 2010 Apr; 51(4):543-50. PubMed ID: 20237034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
    Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
    Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.